MICROWAVE TISSUE COAGULATOR IN LIVER RESECTION FOR CIRRHOTIC-PATIENTS

被引：16

作者：

LAU, WY ^{[1
]}

ARNOLD, M ^{[1
]}

GUO, SK ^{[1
]}

LI, AKC ^{[1
]}

机构：

[1] CHINESE UNIV HONG KONG,PRINCE WALES HOSP,DEPT SURG,SHA TIN,HONG KONG

来源：

AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY | 1992年 / 62卷 / 07期

关键词：

HEPATIC RESECTION; HEPATOCELLULAR CARCINOMA; LIVER CIRRHOSIS; MICROWAVE TISSUE COAGULATOR;

D O I：

10.1111/j.1445-2197.1992.tb07053.x

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

The use of the microwave tissue coagulator was studied on 20 consecutive elective hepatic resections carried out for symptomatic hepatocellular carcinoma with liver cirrhosis. The mean operative blood loss (excluding one patient with hepatic vein injury) was 1132 mL. Five patients required no blood transfusion. The average time taken to coagulate the anticipated liver transection plane was less than 15 min. Apart from the complications similar to those occurring in hepatic resections for cirrhotic patients, higher incidences of intra-abdominal sepsis (20%), sympathetic pleural effusion in the absence of chest or intra-abdominal sepsis (20%), and persistent fever lasting more than 1 week (40%) were encountered. It was considered that these complications were related to the coagulated tissue present in the liver remnants (mean depth of tissue coagulation = 3.8 mm) and concluded that although the hospital mortality rate of 10% and the mean operative blood loss of 1132 mL were acceptably low, microwave liver surgery carried a high morbidity rate which is a drawback in major hepatic resectional surgery.

引用

页码：576 / 581

页数：6

共 20 条

[1] Shiu W., Dewar G., Leung N., Et al., Hepatocellular carcinoma in Hong Kong: A clinical study on 340 cases, Oncology, 47, pp. 241-245, (1990)
[2] Okuda K., Early recognition of hepatocellular carcinoma, Hepatology, 6, pp. 729-738, (1986)
[3] Gozzeti G., Mazziotti A., Cavallari A., Et al., Clinical experience with hepatic resections for hepatocellular carcinoma in patients with cirrhosis, Surg. Gynecol. Obstet., 166, pp. 503-510, (1988)
[4] Garrison R.N., Cryer H.M., Howard D.A., Polk H.C., Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis, Ann. Surg., 199, pp. 648-655, (1984)
[5] Nagao N., Yukaya H., Ogaroa Y., Et al., Hepatic resection for hepatocellular carcinoma: clinical features and long‐term prognosis, Ann. Surg., 105, pp. 33-40, (1987)
[6] Tabuse K., Katsumi M., Kabayashi Y., Et al., Microwave surgery: hepatectomy using a microwave tissue coagulator, World J. Surg., 9, pp. 135-143, (1985)
[7] Delva E., Barberousse J.P., Nordlinger B., Et al., Hemodynamic and biochemical monitoring during major liver resection with use of hepatic vascular exclusion, Surgery, 95, pp. 309-318, (1984)
[8] Bismuth H., Castaing D., Garden O.J., Segmental surgery of the liver, Surgery Annual 1988, 20, pp. 291-310, (1988)
[9] Lee C.S., Sung J.L., Hwang L.Y., Et al., Surgical treatment of 109 patients with symptomatic and asymptomatic hepatocellular carcinoma, Surgery, 99, pp. 481-490, (1986)
[10] Nagasue N., Yukagya H., Ogawa Y., Et al., Hepatic resection in the treatment of hepatocellular carcinoma: report of 60 cases, Br. J. Surg., 72, pp. 292-295, (1985)

← 1 2 →